Tracking treatment delivery during brachytherapy
In-vivo Treatment Verification for HDR Brachytherapy Patients Using an External Imaging Panel
This study is testing a new way to track and confirm that the right dose of brachytherapy is delivered accurately to patients during their treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Sex | All |
| Sponsor | Maastricht Radiation Oncology Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Maastricht, Limburg) |
| Trial ID | NCT06240559 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect data during High Dose Rate (HDR) brachytherapy treatments to verify the accurate delivery of the treatment plan. It utilizes medical imaging techniques such as CT, MRI, and ultrasound, combined with proprietary software, to monitor the brachytherapy source within the patient. The system will be set up beside the treatment table to automatically gather data without interfering with the clinical workflow. The collected data will be analyzed offline to ensure that treatment is not disrupted by any detected errors.
Who should consider this trial
Good fit: Ideal candidates for this study are patients undergoing HDR brachytherapy for gynecological cancers (endometrium/cervix) or prostate cancer.
Not a fit: Patients who are incapacitated or unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance the accuracy of brachytherapy treatments, leading to improved patient outcomes.
How similar studies have performed: While this approach is innovative, similar studies have not been widely reported, indicating that this may be a novel application in the field.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Treatment site Gynaecology (Endometrium/Cervix) and prostate * Treatment: HDR Brachytherapy * Patient will be treated on CT Couch * Mentally competent patient Exclusion Criteria: * Incapacitated patient
Where this trial is running
Maastricht, Limburg
- Maastro — Maastricht, Limburg, Netherlands (Recruiting)
Study contacts
- Principal investigator: Maaike Berbée — Radiotherapist
- Study coordinator: Janneke Waelen
- Email: janneke.waelen@maastro.nl
- Phone: +31 88 445 5334
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.